Heinicke T, Krahl R, Kahl C, Cross M, et al. Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials. Ann Hematol 2021;100:2387-2398.
PMID: 34232360